SWA
GSK icon

Strategic Wealth Advisors’s GSK GSK Stock Holding History

Strategic Wealth Advisors’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5K Hold
120
– – ﹤0.01% 201
2026
Q1 		$6K Hold
120
– – ﹤0.01% 202
2025
Q4 		$5K Buy
+120
New +$5.6K ﹤0.01% 201

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Strategic Wealth Advisors's GSK Position: Q2 2026 in Review

Strategic Wealth Advisors held its GSK (GSK) position steady in Q2 2026 at 120 shares worth $5K. The position accounts for ﹤0.01% of the portfolio, ranked #201.

Strategic Wealth Advisors first reported a position in GSK in Q4 2025 and has held it in 3 quarters since. The position peaked at $6K in Q1 2026. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Strategic Wealth Advisors held 120 shares of GSK worth $5K as of Q2 2026.
  • Strategic Wealth Advisors left its GSK share count unchanged in Q2 2026.
  • GSK made up ﹤0.01% of Strategic Wealth Advisors's portfolio in Q2 2026, its #201 holding.
  • Strategic Wealth Advisors first reported a position in GSK in Q4 2025 and has held it in 3 quarters since.
  • Strategic Wealth Advisors's GSK position peaked at $6K in Q1 2026.
  • 1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Strategic Wealth Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.